These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 8546409
1. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization. Fuller JT, Fuller DH, McCabe D, Haynes JR, Widera G. Ann N Y Acad Sci; 1995 Nov 27; 772():282-4. PubMed ID: 8546409 [No Abstract] [Full Text] [Related]
2. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Whalen RG, Leclerc C, Dériaud E, Schirmbeck R, Reimann J, Davis HL. Ann N Y Acad Sci; 1995 Nov 27; 772():64-76. PubMed ID: 8546414 [Abstract] [Full Text] [Related]
4. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus. Nemecková S, Sroller V, Kunke D, Krystofová J, Kutinová L. Acta Virol; 1996 Nov 27; 40(5-6):273-9. PubMed ID: 9171455 [Abstract] [Full Text] [Related]
5. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice. Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X. J Virol Methods; 2007 Apr 27; 141(1):41-8. PubMed ID: 17197041 [Abstract] [Full Text] [Related]
6. [Immune response in mice induced by the fusion protein of HBcAg and HBV PreS1]. Chen XC, Zhou BP, Li MZ, Wang ZX, Wang HS, Zhang B, Tang W. Zhonghua Gan Zang Bing Za Zhi; 2003 Mar 27; 11(3):184-5. PubMed ID: 12681075 [No Abstract] [Full Text] [Related]
7. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice]. Li L, Tian YJ, Shen H, Zhao XP, Yang DL. Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 27; 17(4):275-9. PubMed ID: 19403026 [Abstract] [Full Text] [Related]
8. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. Kuhöber A, Pudollek HP, Reifenberg K, Chisari FV, Schlicht HJ, Reimann J, Schirmbeck R. J Immunol; 1996 May 15; 156(10):3687-95. PubMed ID: 8621903 [Abstract] [Full Text] [Related]
9. [Study on the immune response of the therapeutic multi-epitope gene vaccine of hepatitis B virus in mice]. Luo LM, Xia H, Liu SR, Li M. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar 15; 27(3):260-2. PubMed ID: 21419043 [Abstract] [Full Text] [Related]
10. Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens. Musacchio A, Rodriguez EG, Herrera AM, Quintana D, Muzio V. Biochem Biophys Res Commun; 2001 Mar 30; 282(2):442-6. PubMed ID: 11401479 [Abstract] [Full Text] [Related]
12. The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens. Chuai X, Xie B, Chen H, Tan X, Wang W, Huang B, Deng Y, Li W, Tan W. Vaccine; 2018 Jun 18; 36(26):3740-3746. PubMed ID: 29778513 [Abstract] [Full Text] [Related]
13. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus. Yang HJ, Chen M, Cheng T, He SZ, Li SW, Guan BQ, Zhu ZH, Gu Y, Zhang J, Xia NS. World J Gastroenterol; 2005 Jan 28; 11(4):492-7. PubMed ID: 15641132 [Abstract] [Full Text] [Related]
14. Nasal route favors the induction of CD4+ T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface- and core-based therapeutic vaccine. Bourgine M, Crabe S, Lobaina Y, Guillen G, Aguilar JC, Michel ML. Antiviral Res; 2018 May 28; 153():23-32. PubMed ID: 29510155 [Abstract] [Full Text] [Related]
15. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. Schirmbeck R, Zheng X, Roggendorf M, Geissler M, Chisari FV, Reimann J, Lu M. J Immunol; 2001 Jan 15; 166(2):1405-13. PubMed ID: 11145726 [Abstract] [Full Text] [Related]
16. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers. Skrastina D, Bulavaite A, Sominskaya I, Kovalevska L, Ose V, Priede D, Pumpens P, Sasnauskas K. Vaccine; 2008 Apr 07; 26(16):1972-81. PubMed ID: 18343539 [Abstract] [Full Text] [Related]
17. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens. Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC. Int J Infect Dis; 2007 Sep 07; 11(5):394-401. PubMed ID: 17257877 [Abstract] [Full Text] [Related]
18. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice. Yu D, Liu H, Shi S, Dong L, Wang H, Wu N, Gao H, Cheng Z, Zheng Q, Cai J, Zou L, Zou Z. Immunol Lett; 2015 Dec 07; 168(2):293-9. PubMed ID: 26475398 [Abstract] [Full Text] [Related]
19. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen. Ulrich R, Borisova GP, Gren E, Berzin I, Pumpen P, Eckert R, Ose V, Siakkou H, Gren EJ, von Baehr R. Arch Virol; 1992 Dec 07; 126(1-4):321-8. PubMed ID: 1381912 [Abstract] [Full Text] [Related]
20. Polyvalent DNA vaccines with bidirectional promoters. Kwissa M, Unsinger J, Schirmbeck R, Hauser H, Reimann J. J Mol Med (Berl); 2000 Dec 07; 78(9):495-506. PubMed ID: 11140375 [Abstract] [Full Text] [Related] Page: [Next] [New Search]